Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GX Genomics & Biotechnology ETF (NQ: GNOM ) 11.37 UNCHANGED Streaming Delayed Price Updated: 4:15 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GX Genomics & Biotechnology ETF 3 Gene Editing Stocks with Potential to Transform Medicine August 09, 2024 Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. Via InvestorPlace The 3 Best Gene Editing Stocks to Buy in July 2024 July 08, 2024 Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. Via InvestorPlace Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life May 10, 2024 Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. Via InvestorPlace 3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire May 02, 2024 Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. Via InvestorPlace 3 Stocks That Could Be the Next Big Thing in Gene Editing March 21, 2024 Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. Via InvestorPlace ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? June 04, 2021 Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category. Via Talk Markets 3 Gene Editing Stocks With Unprecedented Surge Potential February 13, 2024 While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. Via InvestorPlace 3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential January 31, 2024 Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example. Via InvestorPlace 3 Gene Editing Stocks to Generate Super-Charged Gains October 18, 2023 As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks. Via InvestorPlace The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket March 25, 2023 Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it. Via InvestorPlace The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector March 15, 2023 To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. Via InvestorPlace 3 Gene Editing Stocks With the Best Long-Term Potential January 25, 2023 These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space Via InvestorPlace 3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years January 18, 2023 CRISPR could be revolutionary, leading us to put together this list of CRISPR stocks that will make you rich in 10 years. Via InvestorPlace ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM October 21, 2021 The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage. Via Talk Markets A Comprehensive Guide To Genomic ETFs July 11, 2021 Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon... Via Talk Markets Top-Performing Biotech ETFs of Last Week June 14, 2021 Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week. Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.